Moon Surgical, a pioneer in collaborative robotics, today announced that it has secured $31.3 million in Series A funding. The financing round was led by GT Healthcare Capital & Partners, with participation by Johnson & Johnson Innovation – JJDC, Inc. (JJDC), Cathay Health, and existing investor, Sofinnova Partners.
Founded in Paris in 2019 by Pr. Brice Gayet and incubated by Sofinnova MD Start, Moon Surgical has shown its prowess at speed and innovation with early systems already fully functional and driven by more than thirty surgeons across two continents and multiple clinical indications. Moon Surgical aims to revolutionize minimally invasive surgery through the power of collaborative and adaptive robotics. Small, adaptable, and integrated into existing clinical workflows, the Maestro system is designed to support surgeons and patients in the 18.8 million soft-tissue surgery procedures not currently supported by telerobotic systems every year.
Alan Au, Managing Partner of GT Healthcare, who will be joining the board commented: “We are delighted to support this world-class team in reinventing the surgical robotic space. We share the vision of Maestro’s data-driven capabilities in underserved laparoscopic procedures, and hope to support its path in making robotic surgery accessible across all geographies.”
Dr. Steve Oesterle, Venture Partner at Cathay Health, and Dr. Fred Moll, Chief Development Officer for Auris Health, a Johnson & Johnson MedTech company, will be advising the board as unique industry experts.